¼¼°è ¶¡¾ÇÃëÁõ Ä¡·á ½ÃÀå
Bromhidrosis Disease Treatment
»óǰÄÚµå : 1534099
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 250 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,056,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,169,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¶¡¾ÇÃëÁõ Ä¡·á ¼¼°è ½ÃÀåÀº 2030³â±îÁö 12¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2023³â¿¡ 7¾ï 5,630¸¸ ´Þ·¯·Î ÃßÁ¤µÈ ¶¡¾ÇÃëÁõ Ä¡·á ¼¼°è ½ÃÀåÀº 2030³â¿¡´Â 12¾ï ´Þ·¯¿¡ À̸£°í, ºÐ¼® ±â°£ 2023-2030³âÀÇ CAGRÀº 6.8%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ¾ÆÆ÷Å©¸° üÃë Ä¡·á´Â CAGR 7.7%·Î ¼ºÀåÀ» Áö¼ÓÇϰí, ºÐ¼® ±â°£ Á¾·á ½Ã¿¡´Â 7¾ï 4,280¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Eclin ³¿»õ Ä¡·á ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 5.4%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº ÃßÁ¤ 2¾ï 600¸¸ ´Þ·¯, Áß±¹Àº CAGR 11.1%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¶¡¾ÇÃëÁõ Ä¡·á ½ÃÀåÀº 2023³â 2¾ï 600¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2023-2030³â CAGRÀ» 11.1%·Î 2030³â±îÁö 2¾ï 6,460¸¸ ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 2.9%¿Í 6.8%·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 4.3%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ¶¡¾ÇÃëÁõ Ä¡·á ½ÃÀå - ÁÖ¿ä ÃËÁø¿äÀΰú µ¿Çâ Á¤¸®

ÀϹÝÀûÀ¸·Î üÃëÁõÀ¸·Î ¾Ë·ÁÁø ¶¡¾ÇÃëÁõÀº ¶¡ÀÇ ¹ÚÅ׸®¾Æ ºÐÇØ·Î ÀÎÇÑ °úµµÇÏ°í ºÒÄèÇÑ Ã¼Ã븦 Ư¡À¸·ÎÇÏ´Â º´¸®ÀÔ´Ï´Ù. ÀÌ ÁúȯÀº ÁÖ·Î °Üµå¶ûÀÌ¿Í »ì¼­Á¦ µî¿¡¼­ ¹ß°ßµÇ´Â ¾ÆÆ÷Å©¸° ¶¡»ù¿¡ ¿µÇâÀ» ¹ÌĨ´Ï´Ù. ¶¡¾ÇÃëÁõÀº ¾ÆÆ÷Å©¸° ¶¡»ù°ú ¿¡Å©¸° ¶¡»ùÀ¸·Î ºÐ·ùµË´Ï´Ù. ¾ÆÆ÷Å©¸°Çü ¶¡¾ÇÃëÁõÀº ¹ÚÅ׸®¾Æ¿¡ ÀÇÇÑ ¶¡ÀÇ ºÐÇØ¿Í °ü·ÃÀÌ ÀÖÀ¸¸ç, ¿¡Å©¸°Çü ¶¡¾ÇÃëÁõÀº ÇǺΠǥ¸éÀÇ ¿¡Å©¸° ¶¡»ùÀ¸·ÎºÎÅÍÀÇ ¶¡ÀÇ ºÐÇØ¿Í °ü·ÃÀÌ ÀÖ½À´Ï´Ù. ³¿»õÀÇ Ä¡·á´Â ¶¡ÀÇ ºÐºñ¸¦ ÁÙÀÌ°í ¹ÚÅ׸®¾ÆÀÇ È°µ¿À» ÃÖ¼ÒÈ­ÇÏ°í ³¿»õ¸¦ È¿°úÀûÀ¸·Î °ü¸®ÇÏ´Â °ÍÀ» ¸ñÇ¥·ÎÇÕ´Ï´Ù.

¶¡¾ÇÃëÁõÀÇ Ä¡·á´Â ÀÇÇÐÀû Á¢±Ù°ú ºñÀÇÇÐÀû Á¢±ÙÀÌ ¸ðµÎ µµÀԵǾî Å©°Ô ¹ßÀüÇØ ¿Ô½À´Ï´Ù. ÀüÅëÀûÀÎ Ä¡·á¹ýÀ¸·Î´Â ¿°È­¾Ë·ç¹Ì´½À» Æ÷ÇÔÇÑ ±¹¼ÒÁ¦¶¡Á¦³ª µ¥¿Àµµ¶õÆ®Á¦¸¦ »ç¿ëÇÏ¿© ¶¡À» ¾ïÁ¦ÇÏ°í ³¿»õ¸¦ ¼û±â´Â ¹æ¹ýÀÌ ÀÖ½À´Ï´Ù. ½É°¢ÇÑ °æ¿ì¿¡´Â ¹ÚÅ׸®¾Æ °¨¿°À» Ä¡·áÇϱâ À§ÇØ Ç×»ýÁ¦¸¦ ó¹æÇϰųª ÇǺÎÀÇ ¹ÚÅ׸®¾Æ ºÎÇϸ¦ ÁÙÀ̱â À§ÇØ ¼Òµ¶ ¼¼Ã´À» ±ÇÀå ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ º¸Åø¸®´®Åö½Å(º¸Å彺) ÁÖ»ç¿Í °°Àº Ä¡·á¹ýÀº ¶¡À» È긮´Â ½Å°æ ½ÅÈ£¸¦ ÀϽÃÀûÀ¸·Î Â÷´ÜÇÒ ¼ö Àֱ⠶§¹®¿¡ Àα⸦ ²ø°í ÀÖ½À´Ï´Ù. ¶¡»ù Á¦°Å ¹× ±³°¨ ½Å°æ ÀýÁ¦¼ú°ú °°Àº ¼ö¼ú ¿É¼ÇÀº ½É°¢ÇÑ °æ¿ì¿¡ ´õ ¿µ±¸ÀûÀÎ ÇØ°áÃ¥À» Á¦°øÇÕ´Ï´Ù. ÃÖ±ÙÀÇ Áøº¸¿¡´Â ·¹ÀÌÀú Ä¡·á ¹× ¸¶ÀÌÅ©·ÎÆÄ ¿­ºÐÇØ ¿ä¹ýµµ Æ÷ÇԵǾî ÀÖÀ¸¸ç, ÀÌ´Â °úȰ¼º ¶¡»ùÀ» Ç¥ÀûÀ¸·Î ÆÄ±«ÇÏ¿© Áõ»óÀÇ Àå±âÀûÀÎ ¿ÏÈ­¸¦ °¡Á®¿É´Ï´Ù.

¶¡¾ÇÃëÁõ Ä¡·á ½ÃÀåÀÇ ¼ºÀåÀº ¿©·¯ ¿äÀο¡ ÀÇÇØ ÃÊ·¡µË´Ï´Ù. ù°, üÃë¿Í °ü·ÃµÈ ÀǽÄÀÌ ³ô¾ÆÁö°í »çȸÀû ³«ÀÎÀ¸·Î ÀÎÇØ ´õ ¸¹Àº »ç¶÷µéÀÌ Ä¡·á¸¦ ¿ä±¸ÇÏ°Ô µÇ¾î È¿°úÀûÀÎ Ä¡·á¹ý¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. µÑ°, ÇǺΰúÇÐ ¿¬±¸¿Í ±â¼ú Áøº¸·Î Ä¡·á ¿É¼ÇÀÌ È®´ëµÇ¾î ´õ¿í Ä£¼÷Çϰí È¿À²ÀûÀÔ´Ï´Ù. ¶ÇÇÑ, °¡Ã³ºÐ ¼Òµæ Áõ°¡¿Í, ƯÈ÷ °³¹ß µµ»ó Áö¿ª¿¡¼­ÀÇ °Ç°­ °ü¸® ÀÎÇÁ¶óÀÇ °³¼±Àº ºñħ½ÀÀû ¹× ¿Ü°úÀû Ä¡·á ¸ðµÎ¿¡ ´ëÇÑ Á¢±ÙÀ» ¿ëÀÌÇÏ°Ô ÇÏ¿´½À´Ï´Ù. ÀüÀÚ»ó°Å·¡ ¹× ¿ø°Ý ÀÇ·á Ç÷§ÆûÀÇ ¼ºÀåÀº ȯÀÚ°¡ Àü¹®ÀûÀÎ Ä¡·á ¹× ÁøÂû¿¡ Á¢±ÙÇÒ ¼ö ÀÖµµ·Ï ÇÕ´Ï´Ù. °Ô´Ù°¡ ¶¡°ú °ü·ÃµÈ ¹®Á¦¸¦ ÀÏÀ¸Å°±â ½¬¿î ³ëÈ­·Î ÀÎÇØ °í±Þ ¾ÇÇÑ ¶¡¾ÇÃëÁõ Ä¡·áÀÇ Çʿ伺ÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¸¶Áö¸·À¸·Î, Á¦¾àȸ»ç¿Í È­Àåǰȸ»ç°¡ ÀÚ»çÁ¦Ç°ÀÇ ÀÎÁöµµ¿Í ÀåÁ¡À» ³ÐÈ÷±â À§ÇÑ Àü·«Àû ¸¶ÄÉÆÃ È°µ¿ÀÌ ½ÃÀå È®´ë¸¦ ÃËÁøÇϴµ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ ¿¹(Àü 86°Ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Bromhidrosis Disease Treatment Market to Reach US$1.2 Billion by 2030

The global market for Bromhidrosis Disease Treatment estimated at US$756.3 Million in the year 2023, is expected to reach US$1.2 Billion by 2030, growing at a CAGR of 6.8% over the analysis period 2023-2030. Apocrine Body Odor Treatment, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$742.8 Million by the end of the analysis period. Growth in the Eccrine Body Odor Treatment segment is estimated at 5.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$206.0 Million While China is Forecast to Grow at 11.1% CAGR

The Bromhidrosis Disease Treatment market in the U.S. is estimated at US$206.0 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$264.6 Million by the year 2030 trailing a CAGR of 11.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 6.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global Bromhidrosis Disease Treatment Market - Key Drivers and Trends Summarized

Bromhidrosis, commonly known as body odor, is a medical condition characterized by excessive and offensive body odor caused by bacterial decomposition of sweat. This condition primarily affects the apocrine sweat glands found in areas such as the armpits and groin. Bromhidrosis can be classified into two types: apocrine and eccrine. Apocrine bromhidrosis is associated with the bacterial breakdown of sweat, while eccrine bromhidrosis is linked to the decomposition of sweat from the eccrine glands on the skin's surface. Treatment for bromhidrosis aims to reduce sweat production, minimize bacterial activity, and manage the odor effectively.

The treatment landscape for bromhidrosis has evolved considerably, incorporating both medical and non-medical approaches. Traditional treatments include the use of topical antiperspirants and deodorants that contain aluminum chloride to reduce sweat and mask the odor. For more severe cases, physicians may prescribe antibiotics to address bacterial infections or recommend antiseptic washes to reduce bacterial load on the skin. Additionally, treatments such as botulinum toxin (Botox) injections have gained popularity for their ability to temporarily block nerve signals responsible for sweating. Surgical options, including the removal of sweat glands and sympathectomy, offer more permanent solutions for severe cases. Recent advancements also include laser treatments and microwave thermolysis, which target and destroy overactive sweat glands, providing long-term relief from symptoms.

The growth in the bromhidrosis treatment market is driven by several factors. Firstly, the increasing awareness and social stigma associated with body odor have led more individuals to seek medical treatment, boosting demand for effective therapies. Secondly, advancements in dermatological research and technology have expanded treatment options, making them more accessible and efficient. Additionally, the rise in disposable incomes and improved healthcare infrastructure, particularly in developing regions, has facilitated greater access to both non-invasive and surgical treatments. The growth of e-commerce and telemedicine platforms has also made it easier for patients to access specialized treatments and consultations. Furthermore, the aging population, which is more prone to sweat-related issues, has increased the need for advanced bromhidrosis treatments. Lastly, strategic marketing efforts by pharmaceutical and cosmetic companies to promote awareness and the benefits of their products have played a crucial role in driving market expansion.

Select Competitors (Total 86 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â